Acumen Pharmaceuticals Inc. (ABOS) Stock Price

ABOS (Acumen Pharmaceuticals, Inc) - company brandmark

Acumen Pharmaceuticals (ABOS) focuses on developing the selective drug ACU193 to combat amyloid oligomers in Alzheimer's disease. Development is based in Virginia, while drug manufacturing is delegated to external CDMO sites to minimize risks. This daily price chart, which currently shows a level of 0.23, correlates with the company's staffing policy: Acumen Pharmaceuticals (ABOS) attracts compliance experts and neurobiologists through a stock option system.

Market Price: Acumen Pharmaceuticals (ABOS) for 07/04/2022 - 11/11/2026

Acumen Pharmaceuticals Inc. (ABOS) - metric breakdowns and financial figures

Analysis of all company metrics:Acumen Pharmaceuticals ABOS
Signature product of Acumen Pharmaceuticals Inc.

To identify the fundamental leaders of the sector, analysts utilize the business share value, which measures the market recognition of assets and determines investment attractiveness through price volatility. In the case of Acumen Pharmaceuticals (ABOS), this metric reflects market expectations regarding the success of clinical trials for its Alzheimer's disease drug, which directly shapes the asset's market trend.

Analysis of competing companies

Stock Price BIIB|Stock Price neurocrine.com (NBIX)|Stock Price RGC (Regencell Bioscience Holdings Limited)|Axsome - Price Chart|ACAD - Price Chart|Market Price Xenon Corp|Viking Therapeutics (VKTX) - Price Chart|SUPN - Market Chart|Price Chart Catalyst Pharmaceuticals, Inc.|Share Price DNLI (Denali)|Stock Price HRMY|BHVN - Market Price|Amylyx Pharmaceuticals - Stock Quotes|Stock Price trevitherapeutics.com TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex)|CeriBell Corp (CBLL) - Price Chart|Market Price Prothena Corporation plc (PRTA)|ALEC (Alector Inc.) - Stock Price|Stock Price annexonbio.com|Stock Price OMER|Stock Quotes Neurogene Inc NGNE|AC Immune Corp - Stock Quotes|Stock Price Voyager Corp VYGR|NMRA - Price Chart|scilexholding.com (SCLX) - Stock Quotes|TVGN: Stock Price|Market Price Alpha Cognition Inc. (ACOG)|Price Chart Cognition Therapeutics|Share Price IKT (Inhibikase Pharma)|Stock Quotes SAVA (Cassava Sciences, Inc.)|ASRT (assertiotx.com) - Price Performance Chart|Price Chart Coya Therapeutics COYA|VTGN (VistaGen Therapeutics, Inc.) - Quote Chart|Ovid Rx - Stock Price|Price Performance Chart CRVO (CervoMed Corporation)|ATHE: Stock Price|Clene (CLNN) - Stock Price|Price Chart PepGen Inc|JUNS: Price Performance Chart|Price Chart Relmada (RLMD)|Stock Quotes Annovis Bio Corporation ANVS|Stock Price GRCE (Grace Therapeutics)|Stock Price fireflyneuro.com AIFF|ANEW Medical, Inc. - Stock Price|NeuroSense Therapeutics (NRSN) - Stock Quotes|RVPH: Stock Price|Market Price MetaVia (MTVA)|Stock Quotes NRXS|Stock Price Helius Medical Technologies Inc.|Stock Quotes PASG (Passage Bio, Inc.)|Price NEUP|Stock Price NERV (Minerva Neurosciences Corp)|Market Chart Athira Pharma Corp (ATHA)|Addex Therapeutics - Stock Price|Alzamend Neuro, Inc. (ALZN) - Stock Quotes|CYCN: Stock Price|Protagenic Therapeutics, Inc. (PTIX) - Stock Price|Price Chart Pasithea Therapeutics Corp|Price Chart CRGT|Price Chart Avenue Therapeutics (ATXI)|Market Chart brainstorm-cell.com|Stock Price CARA (Cara Therapeutics)|Stock Price Chromocell Therapeutics Corp CHRO|Eliem - Stock Price|ITCI: Price Chart|Longboard Pharmaceuticals (LBPH) - Price Chart|Market Price marinuspharma.com (MRNS)|Price Chart NKGen Biotech|NeuroBo Pharmaceuticals Inc (NRBO) - Market Chart|Price Chart Sage Therapeutics, Inc (SAGE)|Synaptogenix, Inc - Share Price|Stock Price TRVN (Trevena, Inc.)|Vigil Neuroscience Inc. (VIGL) - Market Price|WENA: Stock Quotes|CERE - Stock Price